PLx Pharma Inc.

-0.11 (-0.82%)
Earnings Announcements

PLx Pharma Posts Q4 Loss Per Share $0.87

Published: 03/12/2021 12:49 GMT
PLx Pharma Inc. (PLXP) - .
Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update.
Q4 Loss per Share $0.87.
U.S. Commercial Launch of Vazalore Planned for Q3 2021.
Plx Pharma - As of Dec 31, 2020, Co Had Cash and Cash Equivalents of $22.4 Million.
Co Recognized No Revenue for Q4 of 2020 Compared to $24,000 for Q4 of 2019.
Revenue is expected to be $4.1 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $5.27 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.